Skip to the page

Data / Medical devices / United States / Merz North America, Inc.

Merz North America, Inc.: FDA-registered device maker in Franksville, WI, United States, 3 510(k) clearances and 3 PMA approvals

Merz North America, Inc. is registered with the FDA (registration 2135225) in Franksville, WI, United States. It lists 11 device types. The FDA files 3 510(k) clearances and 3 PMA approvals under its listings, the newest dated November 29, 2017. 4 recall events name it as the recalling firm. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
2135225
FEI number
3003407669
Address
4133 Courtney St., Suite 10, Franksville, WI, United States, 53126
Owner or operator
Merz North America, Inc. (9043404)
Roles
Manufacturer, Repackager or relabeler, Specification developer
First device listed
August 5, 2003
Registered through
2027
Brand names listed
Accessory Kit, CSH Cannula; STERiGLIDE, Coaptite Injectable Implant, Describe, Prolaryn Gel Injectable Implant, Prolaryn Plus Injectable Implant, Radiesse Injectable Implant, Radiesse® (+) and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
November 29, 2017K172689DESCRIBE PFD PatchPKOSubstantially EquivalentMerz North America, Inc.accessdata.fda.gov
April 18, 2006K060815JULIESSE INJECTABLE LARYNGEAL AUGMENTATION IMPLANTMIXSubstantially EquivalentBioform Medical, Inc.accessdata.fda.gov
January 9, 2002K013243COAPTITE LARYNGEAL AUGMENTATION SYSTEM 1CC & O.5CC, MODELS 0008021-1, 0008022-1KHJSubstantially EquivalentBioform, Inc.accessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
December 22, 2006P050052RADIESSE INJECTABLE IMPLANTLMH169June 26, 2026accessdata.fda.gov
December 22, 2006P050037RADIESSE 1.3CC AND 0.3CCLMH147June 26, 2026accessdata.fda.gov
November 10, 2005P040047COAPTITELNM76June 26, 2026accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
September 30, 202086572Class IIOngoingCOAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier iThe Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.accessdata.fda.gov
December 16, 201160851Not yet classifiedTerminatedMERZ AESTHETICS, 27G X 1.0 " (25MM) Cannula, Sterile R, QTY 20, Model 9015M1X20, Distributed by Merz Aesthetics, In., Manufactured by TSK Laboratory. The intended use of the Cannula is the injection of fluids into, or wiMerz Aesthetics is initiating a medical device recall on TSK Closed Tip Cannula (27GA x 25mm) due to a labeling error on the secondary (outer) packaging. The outer package label states that the carton contains Cannulas that are 27GA x 25 mm in size instead of 27G x 38 mm. Length of the cannula is a matter of user preference and is unlikely to impact patient accessdata.fda.gov
August 18, 201160046Not yet classifiedTerminatedMERZ AESTHETICS, Radiesse Volume Advantage 1.5 CC, Injectable Implant, Part Number 8071M0H1 and 8071M0K1, Sterile, Rx ONLY. Part Number 8071M4K1 distributed in Canada Part Number 8071M5 distributed in Europe/Middle East/There is a potential leakage of product that may occur with Merz Aesthetics 1.5cc syringes of Radiesse Dermal Filler. When using the syringe, Health Care Professionals should be alerted to the potential for product that my leak pass the plunger at the proximal end of the syring. The defect may result in infection requiring medical intervention to prevent impaccessdata.fda.gov
April 6, 201158614Not yet classifiedTerminatedRadiesse, Injectable Implant - 1.3cc Syringe, Sterile, Sterilized Using Steam, Use Before 2013-01, Ref 8046M7, Lot 1024417, Manufactured by: BioForm Medical Inc, 4133 Courtney Rd #10 Franksville, WI 53126. Subdermal implMerz Aesthetics, Inc. is recalling 1 lot (1034417) of Radiesse 1.3 cc Implant. The lot was supposed to be scrapped because it had failed to meet its Loss On Drying (LOD) specification. Unfortunately it had been marked as approved, released and shipped.accessdata.fda.gov

Compare with other makers

Updated June 26, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.